Testing the Feasibility of a Novel Growth Monitoring Smartphone App
NCT05829252 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 146
Last updated 2025-03-10
Summary
The goal of this clinical trial is to test the acceptability, feasibility, accuracy and precision of the 'GrowthMonitor' smartphone app in a pilot population.
Conditions
- Short Stature
- Growth Disorders
Sponsors & Collaborators
-
Queen Mary University of London
lead OTHER
Principal Investigators
-
Helen Storr, PhD · Queen Mary University, London
Eligibility
- Min Age
- 1 Year
- Max Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2021-03-18
- Primary Completion
- 2025-01-31
- Completion
- 2025-01-31
Countries
- United Kingdom
Study Locations
More Related Trials
-
A Study to Assess Growth in Children With Idiopathic Short Stature
NCT06309979 ·Status: RECRUITING
-
Study Aimed At Improving Height With Genotonorm In Children Born Little And/Or Light With Growth Retardation At The Age
NCT00174252 ·Status: COMPLETED ·Phase: PHASE3
-
Extension Study of Pegylated Somatropin to Treat Growth Retardation Caused by Endogenous Growth Hormone Deficiency in Children
NCT03290235 ·Status: UNKNOWN ·Phase: PHASE4
-
Web-based Adherence Information Integrated Nurse-led Monitoring Clinic
NCT04244123 ·Status: COMPLETED
-
Treatment Of Short Stature With Genotropin In Children Born Small For Gestational Age Until Final Height
NCT00174421 ·Status: COMPLETED ·Phase: PHASE3
-
A Multicenter Multinational Observational Study of Children With Hypochondroplasia
NCT06212947 ·Status: RECRUITING
-
Pegylated Somatropin (PEG Somatropin) in the Treatment of Children With Growth Hormone Deficiency
NCT03249480 ·Status: UNKNOWN ·Phase: PHASE4
-
Evolution Of Growth Rate In Children With Growth Retardation Due to Glucocorticosteroid Therapy And Treated By Genotonorm
NCT00163189 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Evaluate the Efficacy and Safety of Recombinant Human Growth Hormone in Children With Achondroplasia
NCT05353192 ·Status: UNKNOWN ·Phase: PHASE4
-
Treatment With Recombinant Human Growth Hormone (GH) in Children With Short Stature Secondary to a Long Term Corticoid Therapy
NCT00174187 ·Status: TERMINATED ·Phase: PHASE3
-
Prevention of Growth Retardation by Early Treatment With Growth Hormone (GH) in Children With CJA Treated by Corticosteroid Therapy
NCT00174291 ·Status: TERMINATED ·Phase: PHASE3
-
Treatment With Recombinant Human Growth Hormone Genotonorm (Registered) In Children With Short Stature Secondary
NCT00174278 ·Status: COMPLETED ·Phase: PHASE3
-
Status of Growth Hormone/ Insulin-like Growth Factor-1 (GH/IGF-1) Axis and Growth Failure in Ataxia Telangiectasia (AT)
NCT01052623 ·Status: UNKNOWN ·Phase: PHASE4
-
Validation of Macimorelin as a Test for Adult Growth Hormone Deficiency
NCT02558829 ·Status: COMPLETED ·Phase: PHASE3
-
A Study in Children With Achondroplasia
NCT07301463 ·Status: RECRUITING
-
IGF1 Generation Test
NCT00145457 ·Status: COMPLETED ·Phase: PHASE4
-
The Effect of Androgen and Growth Hormone on Height and Learning in Girls With Turner Syndrome
NCT00029159 ·Status: COMPLETED ·Phase: PHASE3
-
Growth Hormone Treatment in Children Born Small for Gestational Age: Assessment of Satisfaction
NCT00519844 ·Status: COMPLETED ·Phase: PHASE4
-
The IGFBP-3 Stimulation Test: A New Tool for the Diagnosis of Growth Hormone Deficiency in Children.
NCT00235599 ·Status: COMPLETED
-
Somatropin Therapy In Children Born Preterm But Appropriate For Gestational Age
NCT00174460 ·Status: COMPLETED ·Phase: PHASE2
-
Phase IV Clinical Study of Pegylated Somatropin (PEG Somatropin) to Treat Growth Hormone Deficiency Children (Clinical Trial I)
NCT02380235 ·Status: UNKNOWN ·Phase: PHASE4
-
Efficacy and Safety of Growth Hormone Treatment in Juvenile Idiopathic Arthritis
NCT00420251 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy and Safety of a High Dosage Compared to the Label Dosage of Somatropin in Early Pubertal Stage Children With Growth Hormone Deficiency
NCT00191165 ·Status: COMPLETED ·Phase: PHASE3
-
Clinical Study of Pegylated Somatropin to Treat Children Growth Hormone Deficiency
NCT02908958 ·Status: UNKNOWN ·Phase: PHASE4
-
Impact of Screens on Children's Growth
NCT07026812 ·Status: COMPLETED